Unregistered Sales of Equity Securities

Trulieve Cannabis Corp. — Form 8-K Summary

Business context and reporting period

This Form 8-K, dated September 15, 2021 and signed September 17, 2021, reports executive compensation arrangements and related unregistered equity issuances. It does not provide quarterly or annual operating results; therefore, revenue, profit, cash flow, margins, debt, and liquidity metrics are not disclosed in the filing text.

Material compensation and equity arrangements

  • On September 15, 2021, Trulieve granted President and Chief Executive Officer Kim Rivers 2,285,178 restricted share units (RSUs).
  • On the same date, the Company granted Chief Information Officer Jason Pernell 618,901 RSUs. Mr. Pernell is a senior leadership team member but is not identified as the principal executive officer, principal financial officer, or a named executive officer.
  • The RSUs replaced compensatory warrants issued on September 21, 2018: 2,811,159 shares for Ms. Rivers and 761,356 shares for Mr. Pernell, each exercisable at C$6.00 per share.
  • Upon execution of the RSU agreements, the warrants were terminated and cancelled.
  • The Company paid cash consideration of $2.5 million to Ms. Rivers and $625,000 to Mr. Pernell. The filing states that these payments will cover, in part, applicable tax withholding requirements.
  • Each RSU represents the right to receive one subordinate voting share upon settlement. The RSUs were fully vested on the grant date and are scheduled to settle within 60 days following September 15, 2024.

Guidance, risks, contingencies, and unusual items

  • The Company agreed to indemnify each recipient for tax liabilities arising solely from replacing the warrants with RSUs, including certain liabilities or penalties under Section 409A of the Internal Revenue Code.
  • The indemnification excludes ordinary income and withholding taxes attributable to settlement of the RSUs, without regard to the replacement transaction.
  • The transaction is reported as an unregistered sale of equity securities under the Securities Act’s Section 4(a)(2) and/or Regulation D exemptions.
  • The filing does not quantify the accounting expense, fair value, dilution impact, or balance-sheet effect of the RSU awards and cash payments.

Most important facts to verify

  • Confirm the final number of subordinate voting shares issued upon RSU settlement and the resulting ownership dilution.
  • Review Exhibits 10.1 and 10.2 for complete vesting, settlement, tax indemnification, and other contractual terms.
  • Verify the accounting treatment and expense recognition for the cancelled warrants, RSU grants, cash payments, and tax indemnities.
  • Assess whether the replacement awards and cash consideration affect executive compensation disclosures or related-party reporting in subsequent filings.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.